These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34089619)

  • 21. Evaluation of reported contents in prescription and over-the-counter prenatal multivitamins.
    DeSalvo K; Stamm CA; Borgelt LM
    J Am Pharm Assoc (2003); 2018; 58(3):258-267.e3. PubMed ID: 29605475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do pharmacists respond to complaints of acute insomnia? A simulated patient study.
    Kippist C; Wong K; Bartlett D; Saini B
    Int J Clin Pharm; 2011 Apr; 33(2):237-45. PubMed ID: 21394573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent profile of the insomnia severity index: A longitudinal study.
    Wang S; Jülich ST; Lei X
    Sleep Med; 2024 Mar; 115():202-209. PubMed ID: 38368737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription and over-the-counter medication in deliberate self-poisoning and accidental overdosing--preliminary study.
    Szkolnicka B
    Przegl Lek; 2005; 62(6):568-71. PubMed ID: 16225126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of prescription and nonprescription hypnotics in a Canadian elderly population.
    Busto UE; Sproule BA; Knight K; Herrmann N
    Can J Clin Pharmacol; 2001; 8(4):213-21. PubMed ID: 11743594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insomnia, alcohol, and over-the-counter drug use in old-old urban women.
    Johnson JE
    J Community Health Nurs; 1997; 14(3):181-8. PubMed ID: 9282538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches.
    Fisher M; Rawal K
    Ther Innov Regul Sci; 2023 Sep; 57(5):1074-1080. PubMed ID: 37357243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of medication by adolescents for the management of menstrual discomfort.
    Campbell MA; McGrath PJ
    Arch Pediatr Adolesc Med; 1997 Sep; 151(9):905-13. PubMed ID: 9308868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study.
    Lavigne JE; Hur K; Kane C; Au A; Bishop TM; Pigeon WR
    J Gen Intern Med; 2019 Aug; 34(8):1554-1563. PubMed ID: 31161572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between stress-related sleep reactivity and cognitive processes in insomnia disorder and insomnia subgroups: preliminary results.
    Palagini L; Faraguna U; Mauri M; Gronchi A; Morin CM; Riemann D
    Sleep Med; 2016 Mar; 19():101-7. PubMed ID: 27198954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories.
    Bei B; Asarnow LD; Krystal A; Edinger JD; Buysse DJ; Manber R
    J Consult Clin Psychol; 2018 Mar; 86(3):282-293. PubMed ID: 29504795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use.
    Kaufmann R; Bozer AH; Jotte AK; Aqua K
    Med Cannabis Cannabinoids; 2023; 6(1):77-88. PubMed ID: 37900894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use for insomnia in Metropolitan Detroit.
    Roehrs T; Hollebeek E; Drake C; Roth T
    J Psychosom Res; 2002 Jul; 53(1):571-6. PubMed ID: 12127173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician over-the-counter drug prescribing patterns: an analysis of the National Ambulatory Medical Care Survey.
    Pradel FG; Hartzema AG; Mutran EJ; Hanson-Divers C
    Ann Pharmacother; 1999 Apr; 33(4):400-5. PubMed ID: 10332528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the German version of the short form of the dysfunctional beliefs and attitudes about sleep scale (DBAS-16).
    Lang C; Brand S; Holsboer-Trachsler E; Pühse U; Colledge F; Gerber M
    Neurol Sci; 2017 Jun; 38(6):1047-1058. PubMed ID: 28321516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypnotic use and fatigue in multiple sclerosis.
    Braley TJ; Segal BM; Chervin RD
    Sleep Med; 2015 Jan; 16(1):131-7. PubMed ID: 25454981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep phase and pre-sleep arousal predicted co-developmental trajectories of pain and insomnia within adolescence.
    Arnison T; Schrooten MGS; Bauducco S; Jansson-Fröjmark M; Persson J
    Sci Rep; 2022 Mar; 12(1):4480. PubMed ID: 35296699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep-promoting medications in children: physician prescribing habits in Southwestern Ontario, Canada.
    Bock DE; Roach-Fox E; Seabrook JA; Rieder MJ; Matsui D
    Sleep Med; 2016 Jan; 17():52-6. PubMed ID: 26847974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
    Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
    Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between report of insomnia and daytime functioning.
    Ustinov Y; Lichstein KL; Wal GS; Taylor DJ; Riedel BW; Bush AJ
    Sleep Med; 2010 Jan; 11(1):65-8. PubMed ID: 19783473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.